Quadriga Biosciences has a total of 65 patents globally, out of which 32 have been granted. Of these 65 patents, more than 63% patents are active. The United States of America is where Quadriga Biosciences has filed the maximum number of patents, followed by Japan and China. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Quadriga Biosciences.
Quadriga Biosciences was founded in 2015. Quadriga Biosciences is a pharmaceutical corporation. The company discovers and develops exclusive targeted cancer medicines, chemicals, and medications to treat cancer patients. Customers are served by Quadriga Biosciences throughout the state of California.
Do read about some of the most popular patents of Quadriga Biosciences which have been covered by us in this article and also you can find Quadriga Biosciences patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Quadriga Biosciences patent portfolio.
How many patents does Quadriga Biosciences have?
Quadriga Biosciences has a total of 65 patents globally. These patents belong to 5 unique patent families. Out of 65 patents, 41 patents are active.
How Many Patents did Quadriga Biosciences File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Quadriga Biosciences Applications Filed | Quadriga Biosciences Patents Granted |
| 2022 | 6 | 1 |
| 2021 | 1 | 5 |
| 2020 | – | 3 |
| 2019 | 2 | 7 |
| 2018 | 3 | 7 |
| 2017 | 6 | 6 |
| 2016 | 19 | 3 |
| 2015 | 28 | – |
How many Quadriga Biosciences patents are Alive/Dead?
Worldwide Patents
How Many Patents did Quadriga Biosciences File in Different Countries?
Countries in which Quadriga Biosciences Filed Patents
| Country | Patent |
| United States of America | 13 |
| Japan | 7 |
| Taiwan | 4 |
| Australia | 4 |
| China | 4 |
| Korea (South) | 3 |
| Canada | 3 |
| Europe | 3 |
| India | 2 |
| Brazil | 2 |
| Singapore | 2 |
| Israel | 2 |
| Europe | 1 |
| Europe | 1 |
| Argentina | 1 |
| Europe | 1 |
| New Zealand | 1 |
| Europe | 1 |
| Hong Kong (S.A.R.) | 1 |
| Europe | 1 |
| South Africa | 1 |
| Mexico | 1 |
| Europe | 1 |
Where are Research Centers of Quadriga Biosciences Patents Located?
The Research Center for Quadriga Biosciences is the United States of America.
What Percentage of Quadriga Biosciences US Patent Applications Were Granted?
Quadriga Biosciences (Excluding its subsidiaries) has filed 13 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 10 have been granted leading to a grant rate of 76.92%.
Below are the key stats of Quadriga Biosciences patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Quadriga Biosciences?
| Law Firm | Total Applications | Success Rate |
| Sheppard Mullin Richter & Hampton Llp | 13 | 76.92% |
What are Quadriga Biosciences key innovation segments?
What Technologies are Covered by Quadriga Biosciences?
The chart below distributes patents filed by Quadriga Biosciences